{"schema_version":"1","generated_at":"2026-11-10T05:01:21.122Z","data_as_of":null,"url":"https://www.findmykol.com/kol/dipenkumar-modi","json_url":"https://www.findmykol.com/kol/dipenkumar-modi/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"dipenkumar-modi","name":"Dipenkumar Modi","credential":"MD","specialty":"Internal Medicine","specialty_raw":"Internal Medicine","therapeutic_area":"Primary Care","therapeutic_areas":["Primary Care"],"city":"Detroit","state":"MI","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1821344656","orcid":"0000-0001-6525-8844","openalex":"A5086490383"},"summary":"Dipenkumar Modi is a Primary Care physician. OpenAlex indexes 158 publications with 1,404 citations (h-index 20); ClinicalTrials.gov lists 6 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Primary Care"]},"scholarship":{"works_count":158,"cited_by_count":1404,"h_index":20,"latest_activity_year":2025,"source":"works"},"trials":{"count":6,"shown":3,"withheld":3,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT05852717","title":"Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma","phase":"PHASE2","status":"RECRUITING","role":"Overall official","sponsor":"Dipenkumar Modi","source_url":"https://clinicaltrials.gov/study/NCT05852717","trial_url":"https://www.findmykol.com/trial/NCT05852717"},{"nct":"NCT05222438","title":"Trial of Loncastuximab Tesirine in High Risk Diffuse Large B-cell Lymphoma Post Transplant","phase":"PHASE2","status":"WITHDRAWN","role":"Overall official","sponsor":"Barbara Ann Karmanos Cancer Institute","source_url":"https://clinicaltrials.gov/study/NCT05222438","trial_url":"https://www.findmykol.com/trial/NCT05222438"},{"nct":"NCT04479267","title":"Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously Untreated Lymphoma","phase":"PHASE2","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"Barbara Ann Karmanos Cancer Institute","source_url":"https://clinicaltrials.gov/study/NCT04479267","trial_url":"https://www.findmykol.com/trial/NCT04479267"}],"source":"trials"},"payments":{"company_count":16,"program_years":{"first":2021,"last":null},"rows_total":78,"shown":3,"withheld":75,"rows":[{"payer":"Regeneron","program_year":2025,"amount_usd":694388.65,"payment_count":130,"source_url":"https://openpaymentsdata.cms.gov/search?query=1821344656"},{"payer":"Bristol Myers Squibb","program_year":2025,"amount_usd":228083.84,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1821344656"},{"payer":"Genentech","program_year":2025,"amount_usd":188309.6,"payment_count":48,"source_url":"https://openpaymentsdata.cms.gov/search?query=1821344656"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1821344656","source":"payments"},"similar":[{"name":"Fei Wang","slug":"fei-wang","institution":"Cornell University","specialty":"Family Medicine","url":"https://www.findmykol.com/kol/fei-wang","json_url":"https://www.findmykol.com/kol/fei-wang/profile.json"},{"name":"Michael Hassman","slug":"michael-hassman","specialty":"Adult Medicine","url":"https://www.findmykol.com/kol/michael-hassman","json_url":"https://www.findmykol.com/kol/michael-hassman/profile.json"},{"name":"Barbara Rizzardi","slug":"barbara-rizzardi","specialty":"Internal Medicine","url":"https://www.findmykol.com/kol/barbara-rizzardi","json_url":"https://www.findmykol.com/kol/barbara-rizzardi/profile.json"},{"name":"Kimball Johnson","slug":"kimball-johnson","specialty":"Internal Medicine","url":"https://www.findmykol.com/kol/kimball-johnson","json_url":"https://www.findmykol.com/kol/kimball-johnson/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":3,"payments":75}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}